References
- Blumer D, Heilbrom M. The pain-prone disorder: a clinical and psychological profile. Psychosomatics 1981; 22: 395–402
- Bradley JJ. Severe localized pain associated with the depressive syndrome. Br J Psychiatry 1963; 109: 741–5
- Pilowsky I, Chapman C P, Bonica JJ. Pain, depression and illness behavior in a pain chronic population. Pain 1977; 4: 183–92
- Magni G, Merskey H. A simple examination of the relationships between pain, organic lesions and psychiatric illness. Pain 1987; 29: 295–300
- Eberhard G, von Knorring L, Nilsson HL, et al. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes. Neuropsychobiology 1988; 19: 25–34
- Kupfer D J, Reynolds CF. The Origins of Depression: Current concepts and approaches, J Angest. Springer-Verlag, Berlin 1983; 235–52
- Arana G W, Baldessarini RJ. Clinical use of the dexamethasone suppression test in psychiatry. Psychopharmacology. The Third Generation of Progress, HY Meltzer, et al. Raven Press, New York 1987; 609–27
- Prange A J, Garbutt C, Loosen PT. The hypothalamic-pituitary-thyreoid axis in affective disorders. Psychopharmacology. The Third Generation of Progress, HY Meltzer, et al. Raven Press, New York 1987; 629–54
- Laakmann G. Antidepressants. Clinical psychopharmachology, H Hippius, G Winokur. Excerpta Medica, Amsterdam 1983; 2: 86–96
- Lerner P, Major L P, Ziegler M. Central noradrenergic adaption to long-term treatment with imipramine in rhesus monkeys. Brain Research 1980; 200: 220–4
- Åsberg M, Thorén P, Träskman L, et al. “Serotonin depression” - A biochemical subgroup within the affective disorders. Science 1976; 191: 478–80
- Åsberg M, Traskman L, Thorén P. 5-HIAA, in the cerebrospinal fluid. Arch Gen Psychiatry 1976; 33: 1193–7
- Åsberg M, Bertilsson L, Mårtensson B, et al. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 1984; 69: 201–19
- Gjerris A. Baseline studies on transmitter substances in cerebrospinal fluid in depression. Acta Psychiatr Scand 1988; 346, supl
- Oreland L, Wiberg Å, Åsberg M, et al. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy control. Psychiatry Res 1981; 4: 21–9
- Banki C M, Molnar G, Vojnik M. Cerebrospinal fluid amine metabolites, tryptophan and clinical parametres in depression. Psychopathological symptoms. J Affective Disord 1981; 3: 91–9
- Ågren H. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in cerebrospinal fluid: II Suicide. Psychiatry Res 1980; 3: 225–36
- López-Ibor JJ, Jr., Saiz-Ruiz J, de los Cobos J CP. Biological correlations of suicide and aggressivity in major depressions (with melancholia): 5-hy-droxyindoleacetic aeid and Cortisol in cerebral spintal fluid, dexamethasone suppression test and therapeutic response to 5-hydroxytryptophan. Neuropsychobiol 1985; 14: 67–74
- Banki C M, Arató M. Amine metabolites, neuroendocrine findings and personality dimensions as correlates of suicidal behaviour. Psychiatr Res 1983; 10: 253–61
- Träskman L, Åsberg M, Bertilsson L, et al. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 1981; 38: 631–6
- Ninan P T, van Kammen D P, Scheinen M, et al. CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. Am J Psychiatry 1984; 141: 566–9
- Langer S Z, Raisman R. Binding of 3H-imipra-mine and 3H-desimipramine as biochemical tools for studies in depression. Neuropharmacology 1983; 22: 407–13
- Plenge P, Mellerup E T, Gjerris A. Imipramine binding in depressive patients diagnosed according to different criteria. Acta Psychiatr Scand 1988; 78: 156–61